1 Min Read
* Biosyent pharma receives health canada approval for new urgent care product using the aguettant system(r) Source text for Eikon: Further company coverage: (Bengaluru Newsroom +1-646-223-8780)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.